#126 Drug Discovery is Becoming More $$$ — Here's Why, And The Startup Fixing It (Lindus Health) - a podcast by Mustafa Sultan

Drug discovery is becoming more expensive and producing less results than ever before (Eroom's Law)—why?

One of the ballooning costs are clinical trials. Pharma/biotech often outsource their trials to CROs (contract research organisations).

But many CROs are incentivised to make trials as bloated and inefficient as possible. That means more money and less results.

Meri Beckwith is building the anti-CRO: Lindus Health—to solve this problem.

0:00 Intro

1:39 The big problem in drug discovery

4:10 Why do CROs exist?

7:24 The incentive problem in drug discovery/CROs

10:57 Pharma are anti-startups

12:11 How much a clinical trial costs

15:11 How can you compete with big CROs?

17:26 Are you going to build your own drug pipeline?

18:56 Lessons from VC to Founder

23:42 Brand/PR/Positioning as a biotech startup

29:03 Billion dollar ideas in bio/health

31:33 Habits that have helped Meri

Links

Lindus Health: https://www.lindushealth.com/

Meri Beckwith: https://twitter.com/meribeckwith

Mithi Thaya: https://www.linkedin.com/in/mithi-thaya/

Dr Mustafa Sultan: https://www.musty.io/

Further episodes of Big Picture Medicine

Further podcasts by Mustafa Sultan

Website of Mustafa Sultan